Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Current Issues in Pharmacy and Medical Sciences
Volume 36 (2023): Issue 2 (June 2023)
Open Access
The role of the L-arginine-NO-cGMP pathway in the development of tolerance to mephedrone-induced hyperlocomotion in mice
Gabriela Bielecka-Papierz
Gabriela Bielecka-Papierz
,
Ewa Poleszak
Ewa Poleszak
,
Aleksandra Szopa
Aleksandra Szopa
,
Joanna Listos
Joanna Listos
,
Jolanta Orzelska-Gorka
Jolanta Orzelska-Gorka
,
Małgorzata Jakobczuk
Małgorzata Jakobczuk
,
Kamila Baluk
Kamila Baluk
,
Sylwia Talarek
Sylwia Talarek
and
Anna Serefko
Anna Serefko
| Jun 30, 2023
Current Issues in Pharmacy and Medical Sciences
Volume 36 (2023): Issue 2 (June 2023)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Jun 30, 2023
Page range:
114 - 120
Received:
Mar 30, 2023
Accepted:
May 05, 2023
DOI:
https://doi.org/10.2478/cipms-2023-0020
Keywords
mephedrone
,
L-NAME
,
methylene blue
,
L-arginine hydrochloride
,
sildenafil citrate
,
mice
© 2023 Gabriela Bielecka-Papierz et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.